Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vasopressin: improving resuscitation?

Dan Hatlestad1

  • 1Inter-Canyon Fire/Rescue, Morrison, CO, USA. prioritymed@mindspring.com

Emergency Medical Services
|May 11, 2004
PubMed
Summary

Vasopressin shows promise as a cardiac arrest treatment, offering potent vasoconstriction without epinephrine's harmful side effects. Further research is needed to confirm its impact on neurologically intact patient survival in emergency medical services.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Carbon monoxide poisoning: incidence, diagnosis & treatment.

Emergency medical services·2005
Same author

Capnography in sedation and pain management.

Emergency medical services·2005
Same author

Capnography as a predictor of the return of spontaneous circulation.

Emergency medical services·2004
Same author

Purchasing EMS monitoring equipment: balancing price, purpose and performance.

Emergency medical services·2004
Same author

Asthma. An acute and chronic problem for EMS.

Emergency medical services·2004
Same author

Biphasic defibrillation. The shape of resuscitation today.

Emergency medical services·2004

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Pharmacology

Background:

  • Epinephrine is a standard cardiac arrest treatment, promoting perfusion via vasoconstriction.
  • Epinephrine's non-selective receptor activity can negatively impact cardiac function and oxygen demand.
  • Vasopressin presents a potential alternative or adjunct due to its selective vasoconstrictive properties.

Purpose of the Study:

  • To evaluate vasopressin as a potential alternative or adjunctive therapy to epinephrine in cardiac arrest.
  • To compare the effects of vasopressin and epinephrine on myocardial workload and oxygen demand.
  • To assess the impact of vasopressin on patient outcomes in the context of North American Emergency Medical Services (EMS).

Main Methods:

  • Review of existing pharmacological data on epinephrine and vasopressin in cardiac arrest.
  • Analysis of recent studies investigating vasopressin's efficacy.
  • Focus on outcome measures including neurologically intact survival and discharge rates.

Main Results:

  • Vasopressin induces potent, selective vasoconstriction.
  • Unlike epinephrine, vasopressin does not increase myocardial workload or oxygen demand.
  • Current data suggests promising outcomes for vasopressin in cardiac arrest scenarios.

Conclusions:

  • Vasopressin may be a safer alternative or adjunct to epinephrine in cardiac arrest management.
  • Its selective action avoids detrimental effects on cardiac function seen with epinephrine.
  • Additional research is necessary to validate vasopressin's efficacy in improving patient survival and neurological outcomes within EMS settings.

Related Experiment Videos